Ziekenhuis Gelderse Vallei
- Address
- Wille Brandtlaan 10, 6716 RP, Ede, The Netherlands
Ziekenhuis Gelderse Vallei - Cardiovascular Research Center
Ziekenhuis Gelderse Vallei is a specialized medical research center focused on advancing treatment strategies for cardiovascular and vascular diseases. The center demonstrates particular expertise in peripheral arterial disease (PAD) management, investigating innovative approaches to optimize patient outcomes through precision medicine methodologies.
- Genotype-guided antithrombotic treatment strategies
- Prevention of major adverse cardiovascular events (MACE)
- Major adverse limb events and limb ischemia management
The research team specializes in evaluating personalized therapeutic interventions aimed at reducing arterial thrombosis complications in vascular disease patients. Their clinical investigations encompass comprehensive cardiovascular endpoints including myocardial infarction, stroke, and transient ischemic attacks, as well as limb-specific outcomes such as acute and chronic limb ischemia requiring peripheral vascular intervention or amputation. This multidisciplinary approach positions the center at the forefront of precision cardiovascular medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ziekenhuis Gelderse Vallei
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Genotype-Guided Antithrombotic Therapy with Carbasalate Calcium, Telmisartan, and Rivaroxaban in Peripheral Arterial Disease Patients | Radboud universitair medisch centrum Stichting | Phase III | Not Recruiting | Dec 2024 | May 2025 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carbasalate Calcium | 1 | Unknown | 2024-12-13 | 2024-12-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.